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It is now just over six years [1] since
many medical journals began requiring
that trials be registered before considering
the trial report for publication. Such a
policy was set up explicitly to reduce what
was considered to be widespread bias in
favor of publication of ‘‘positive’’ trials and
to ensure that all clinical trials be made
public prior to participant enrollment.
Given the importance of clinical trials for
estimating the efficacy and safety of
interventions, and their role in approval
of new drugs and devices, such a policy
seemed uncontroversial. Although it is
known that some trials still go unregis-
tered, there are strong incentives (such as
journal publication) and, in some countries
legally enforceable mandates, for authors
to register these studies before enrolling
patients. The existence and widespread
uptake of trial registration helps research-
ers, patients, and funders understand how
many trials are being undertaken and
which interventions are being evaluated.
It also allows studies to be traced from
inception through to completion and
publication [2].
However, well-conducted systematic re-
views—overviews of health care interven-
tions that use a predefined, explicit
methodology to find and synthesize all
the relevant evidence—are generally con-
sidered higher-caliber evidence than are
individual trials in decision-making for
clinical practice and health policy. The
superiority given to such reviews derives
from key aspects inherent to the process of
carrying out a systematic review. This
study type, if done properly, allows the
review to come closer to estimating the
true effect of an intervention than any
single study can, for two main reasons.
First, such reviews collect and synthesize
all relevant studies; second, reviews ap-
praise each included study for risk of bias.
However, there is increasing evidence of
the existence of publication bias for
systematic reviews. A recent survey [3]
indicates that nonpublication of completed
studies may be as much of a problem for
systematic reviews as it is for trials. Other
analyses [4,5] point to the existence of
discrepancies between systematic review
protocols and the published report, with
one study [5] showing that the outcomes
included in published systematic reviews
may be biased toward ‘‘positive’’ findings.
It is crucially important, therefore, that if
the evidence from these studies is to be
incorporated into clinical practice, the
review is as rigorous and as fully reported
as possible. For example, it should be
obvious to readers whether there was a
prespecified protocol for the review, that
deviations are noted, and whether out-
comes from the review are reported
according to the original study plan.
Increased clarity surrounding systematic
review conduct and reporting would be
possible if the protocols for systematic
reviews, just like those for trials, were
registered [6,7].
Systematic reviews conducted under the
auspices of the Cochrane Collaboration
are registered early, at the protocol
development stage. This registration helps
minimize bias in the conduct and report-
ing of the review, reduce duplication of
effort between groups, and keep systematic
reviews updated. However, until now no
overarching registry open to all research-
ers, worldwide, has existed for recording
the existence and development of system-
atic reviews from inception through to
completion.
This month, the Centre for Reviews
and Dissemination (University of York,
UK), supported by the UK National
Institutes of Health Research and in
collaboration with an international advi-
sory group, announces PROSPERO, its
international Prospective Register of On-
going Systematic Reviews. Following
months of public consultation, with many
hundreds of respondents from 34 countries
providing input on the proposed registra-
tion process and minimum dataset,
PROSPERO is now open for business
[8]. Registration is free, is available to
anyone around the world, and generates a
unique identifying number for each regis-
tered systematic review, which can (and
should) be reported in any publications
that arise from the study. Investigators
should use the registry to record the
existence of the protocol for a planned or
ongoing systematic review of health care
interventions even before screening studies
for inclusion in the systematic review. A
minimum dataset specifies the key items
that are required for a systematic review to
be meaningfully registered. Key data items
include a statement of the research
question, patients and population, study
intervention(s) and outcomes; criteria for
inclusion and exclusion of studies in the
systematic review; outline of search strat-
egy; and methods to assess risk of bias and
for analysis of studies included in the
systematic review.
With a clear system in place for
registration of new and ongoing systematic
reviews, PLoS Medicine announces its sup-
port for this initiative. The journal wishes
to promote best practice in the conduct
and reporting of systematic reviews. Best
practice includes registration during the
protocol phase in PROSPERO or other
appropriate registry, conduct of the review
in accordance with a fully developed
protocol, and reporting in line with the
PRISMA guidelines [9]. PLoS Medicine and
other PLoS journals will now start asking
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their systematic review, and if so, to
provide us with the registry number,
which will be included in the final
published article if the study is accepted
for publication in the journal. We will also
encourage authors to submit copies of
their protocols, which will be available for
reviewers and editors as part of the review
process, and then published as supporting
information alongside the full report of the
systematic review.
We recognize that it is still early days for
registration of systematic reviews. As a
result, the PLoS Medicine editors are keen to
hear from our readers and authors about
this new initiative. We recognize that
efforts such as this cannot alone eliminate
bias in the conduct and reporting of
research. We also appreciate that an
additional burden is posed to prospective
authors; as such we will reassess the PLoS
policy on systematic review registration
within a year. The research community is
still in the process of learning what the
publication outcomes are of cohorts of
trials registered in the main registries, such
as ClinicalTrials.gov and ISRCTN, since
these sites were set up and widely
supported by medical journals [2]. It will
be some time before the uptake and
outcomes of systematic review registration
are known. We hope, however, that the
future success of this initiative will con-
tribute toward increased rigor and trans-
parency of the systematic review literature.
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